World's Best Scientists 2026 revealed!
Peter B. Berger

Peter B. Berger

D-Index & Metrics

Medicine

D-Index
113
Citations
56420
World Ranking
4880
National Ranking
2643

Overview

Peter B. Berger is affiliated with Duke University in the United States. Their research primarily focuses on Medicine, with particular attention to the subfields of Cardiology and Cardiovascular Medicine, Surgery, Economics and Econometrics, Oncology, and General Health Professions.

Their work covers several main research topics including Acute Myocardial Infarction Research, Cardiac, Anesthesia and Surgical Outcomes, Coronary Interventions and Diagnostics, COVID-19 and healthcare impacts, Cardiac Imaging and Diagnostics, Cardiac Arrest and Resuscitation, and Healthcare Policy and Management.

Recent publications by Peter B. Berger include the following papers:

  • Percutaneous Coronary Intervention With and Without Intravascular Ultrasound for Patients With Complex Lesions: Utilization, Mortality, and Target Vessel Revascularization (2022), published in Circulation Cardiovascular Interventions
  • Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction Before and During COVID in New York (2020), published in The American Journal of Cardiology
  • The Association of Socioeconomic Factors With Percutaneous Coronary Intervention Outcomes (2021), published in Canadian Journal of Cardiology
  • Ad Hoc Percutaneous Coronary Intervention in Stable Patients With Multivessel or Unprotected Left Main Disease (2023), published in JACC: Cardiovascular Interventions
  • Regional Systems of Care Demonstration Project: American Heart Association Mission: Lifeline STEMI Systems Accelerator (2020), published in UNC Libraries

Peter B. Berger has frequently collaborated with several co-authors across multiple publications. Notable frequent co-authors include Edward L. Hannan, Alice K. Jacobs, Frederick S. Ling, Spencer B. King, and Ferdinand J. Venditti.

The scientist's publication record shows recurring contributions to these venues:

  • The American Journal of Cardiology (3 publications)
  • UNC Libraries (3 publications)
  • Circulation Cardiovascular Interventions (1 publication)
  • Canadian Journal of Cardiology (1 publication)
  • JACC: Cardiovascular Interventions (1 publication)

In addition to journal articles, Peter B. Berger has authored a book titled Das unrettbare Ich und die Bühne (2020), published by V&R unipress eBooks.

Best Publications

  • Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events

    Deepak L. Bhatt;Keith A.A. Fox;Werner Hacke;Peter B. Berger

  • Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.

    Steven R. Steinhubl;Peter B. Berger;J. Tift Mann;Edward T. A. Fry

  • Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention

    Charanjit S. Rihal;Stephen C. Textor;Diane E. Grill;Peter B. Berger

  • Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy

    Leslee J. Shaw;Daniel S. Berman;David J. Maron;G. B. John Mancini

  • Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial.

    Matthew J. Price;Peter B. Berger;Paul S. Teirstein;Jean-François Tanguay

  • Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention

    Matthew J. Price;Peter B. Berger;Paul S. Teirstein;Dominick J. Angiolillo

  • Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis

    S. G. Chu;R. C. Becker;P. B. Berger;D. L. Bhatt

  • The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

    James D. Douketis;Peter B. Berger;Andrew S. Dunn;Amir K. Jaffer

  • Variability in platelet responsiveness to clopidogrel among 544 individuals.

    Victor L. Serebruany;Steven R. Steinhubl;Peter B. Berger;Alex I. Malinin

  • Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial

    Deepak L. Bhatt;Marcus D. Flather;Werner Hacke;Peter B. Berger

  • Oxidized Phospholipids, Lp(a) Lipoprotein, and Coronary Artery Disease

    Sotirios Tsimikas;Emmanouil S. Brilakis;Elizabeth R. Miller;Joseph P. McConnell

  • The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions.

    Patricia J.M Best;Ryan Lennon;Henry H Ting;Malcolm R Bell

  • Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb) trial.

    Peter B. Berger;Stephen G. Ellis;David R. Holmes;Christopher B. Granger

  • Abciximab in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention After Clopidogrel Pretreatment: The ISAR-REACT 2 Randomized Trial

    Adnan Kastrati;Julinda Mehilli;Franz-Josef Neumann;Franz Dotzer

  • Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study.

    Roxana Mehran;Usman Baber;Philippe Gabriel Steg;Cono Ariti

  • A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel.

    Adnan Kastrati;Julinda Mehilli;Helmut Schühlen;Josef Dirschinger

  • Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative

    Deepak L. Bhatt;Matthew T. Roe;Eric D. Peterson;Yun Li

  • Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point.

    Gjin Ndrepepa;Peter B. Berger;Julinda Mehilli;Melchior Seyfarth

  • Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay: Impact on Thrombosis and Safety (GRAVITAS) trial.

    Matthew J. Price;Dominick J. Angiolillo;Paul S. Teirstein;Elizabeth Lillie

  • Point-of-Care Measured Platelet Inhibition Correlates With a Reduced Risk of an Adverse Cardiac Event After Percutaneous Coronary Intervention Results of the GOLD (AU-Assessing Ultegra) Multicenter Study

    Steven R. Steinhubl;J. David Talley;Gregory A. Braden;James E. Tcheng

Frequent Co-Authors

David R. Holmes
David R. Holmes Mayo Clinic
Eric J. Topol
Eric J. Topol Scripps Research Institute
Steven R. Steinhubl
Steven R. Steinhubl Scripps Health
Ryan J. Lennon
Ryan J. Lennon Mayo Clinic
Christopher B. Granger
Christopher B. Granger Duke University
Adnan Kastrati
Adnan Kastrati Technical University of Munich
Robert M. Califf
Robert M. Califf Duke University
Deepak L. Bhatt
Deepak L. Bhatt Mount Sinai Hospital
David J. Moliterno
David J. Moliterno University of Kentucky
Emmanouil S. Brilakis
Emmanouil S. Brilakis Abbott Northwestern Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those exploring alternative healthcare careers beyond studying Medicine in the USA, online degrees have opened up exciting and flexible options. One popular choice for quick entry into the field is registered nursing. There are cheapest online accelerated bsn programs available for students who want to become registered nurses efficiently and affordably.

If you’re already an RN, advancing your education can be more accessible with cheap rn to bsn programs designed for working professionals. For those aiming for leadership or teaching roles, pursuing one of the cheapest dnp programs can lead to even greater career opportunities.

Finally, if you don’t have a nursing background but aspire to higher-level nursing roles or advanced practice, consider direct entry nurse practitioner programs for non-nurses online. These pathways offer streamlined routes into rewarding healthcare careers, making it easier to pivot to nursing without prior experience in the field.

Best Scientists Citing Peter B. Berger

Trending Scientists